Lifecore biomedical provides update for development portfolio and timing of delayed filings

Chaska, minn., oct. 10, 2023 (globe newswire) -- lifecore biomedical, inc. (“lifecore” or the “company”), a fully integrated contract development and manufacturing organization (“cdmo”), today provided an update on its delayed filings. the company anticipates reporting its fiscal 2024 first quarter results in late october or early november, pending completion of its annual audit, and will make a formal announcement via press release once the date is established.
LFCR Ratings Summary
LFCR Quant Ranking